» Articles » PMID: 25208301

Association of CYP17A1 Gene -34T/C Polymorphism with Polycystic Ovary Syndrome in Han Chinese Population

Overview
Publisher Informa Healthcare
Date 2014 Sep 11
PMID 25208301
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the influence of the cytochrome P450 17α (CYP17A1) gene -34T/C polymorphism in the pathogenesis of polycystic ovary syndrome (PCOS) in Han Chinese population.

Methods: Three-hundred eighteen patients with PCOS and 306 controls were recruited and the CYP17A1 -34T/C polymorphism was genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Furthermore, the relationship of CYP17A1 -34T/C polymorphism and clinical feature parameters of PCOS patients was also analyzed.

Results: The prevalence rates of CYP17A1 genotype TT, TC and CC were 49.69%, 43.71% and 6.6% in the case group and those were 44.77%, 46.08% and 9.15% in the control group. The frequencies of CYP17A1 T and C alleles were 71.54% and 28.46% in the case group, and those were 67.81% and 32.19% in the control group. Neither the genotypic nor the allelic distribution was significantly different between the cases and controls. However, the PCOS patients with the genotype of CC had significantly higher total testosterone levels and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) than those with the genotype of TT or TC.

Conclusions: The CYP17A1 gene -34T/C polymorphism might not be directly correlated with the PCOS, but might influence PCOS via the association of testosterone level and the HOMA-IR.

Citing Articles

Exploring the Association of Biochemical Characterization and Genetic Determinants of TNF-α, CXCR2, and CCR5 Delta 32 Mutation with Predisposition to Polycystic Ovary Syndrome.

Almasoudi K, Hussain E, Almotairi R, Bhat T, Mtiraoui N, Ezzidi I Life (Basel). 2024; 14(8).

PMID: 39202691 PMC: 11355235. DOI: 10.3390/life14080949.


CYP17A1 (rs74357) polymorphism and polycystic ovary syndrome risk: a systemic review and meta-analysis.

Rezgoun M, El Khour D, Bendaoud H, Chellat D Acta Biomed. 2023; 94(4):e2023167.

PMID: 37539608 PMC: 10440780. DOI: 10.23750/abm.v94i4.14229.


The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-Analysis.

Xing C, Zhao H, Zhang J, He B Front Physiol. 2022; 13:741285.

PMID: 35615684 PMC: 9124751. DOI: 10.3389/fphys.2022.741285.


Association Between the Polymorphism of Steroid Hormone Metabolism Genes and High-Altitude Pulmonary Edema in the Chinese Han Population.

Gao H, Xu J, Ma Q, Tang F, Ga Q, Li Y Int J Gen Med. 2022; 15:787-794.

PMID: 35087285 PMC: 8787081. DOI: 10.2147/IJGM.S345495.


CYP17 T/C (rs74357) gene polymorphism contributes to polycystic ovary syndrome susceptibility: evidence from a meta-analysis.

Liu X, Xu M, Qian M, Yang L Endocr Connect. 2021; 10(12):R305-R316.

PMID: 34788226 PMC: 8679930. DOI: 10.1530/EC-21-0327.